# The MAGiC™ Cardiac Ablation European Study

Study · id `cardio:ct-nct06019845` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06019845](<https://clinicaltrials.gov/study/NCT06019845>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06019845

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06019845. Allocation not applicable; no masking; primary purpose treatment. Start 2024-01-02 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06019845, source copy `cardio:ctgov-nct06019845-2026-11-17`, retrieved 2026-11-18)
- Started: 2024-01-02 (actual) (ClinicalTrials.gov record NCT06019845, source copy `cardio:ctgov-nct06019845-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06019845, source copy `cardio:ctgov-nct06019845-2026-11-17`, retrieved 2026-11-18)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT06019845, source copy `cardio:ctgov-nct06019845-2026-11-17`, retrieved 2026-11-18)
- Countries: Denmark; Lithuania; Netherlands; Poland (ClinicalTrials.gov record NCT06019845, source copy `cardio:ctgov-nct06019845-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06019845-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: The MAGiC™ Cardiac Ablation European Study
- Acronym: MAGiC-FESTPMCF
- Condition: Arrhythmias, Cardiac
- Intervention (Device): MAGiC™
- Lead sponsor: Stereotaxis
- Lead sponsor class: INDUSTRY
- Collaborator: Osypka AG
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry condition terms include this condition: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Stereotaxis (`cardio:org-stereotaxis`)

## Provenance

Content hash: eec70943152a6c98c4c20492eed252eb64fc0fd3ea864980fe3564cd4e28a574
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
